This inventor holds 3 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 2004-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2007
Title: Kengo Ikegami: Innovator in Sustained-Release Preparations
Introduction
Kengo Ikegami is a notable inventor based in Nishinomiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sustained-release preparations. With a total of 3 patents to his name, Ikegami's work has the potential to enhance drug delivery systems.
Latest Patents
Ikegami's latest patents include innovative methods for creating sustained-release preparations. One of his notable inventions is a sustained-release preparation that comprises a drug-containing core substance and a multilayered coating layer. This coating layer features adjacent layers containing different hydrophobic organic compound-water-soluble polymer mixtures. The method involves spray-coating a solution onto the core substance and repeating the process with different mixtures. Another significant patent is a preparation method for drug-containing spherical fine particles. This method allows for the production of easily-swallowed, controlled-release preparations by using a binder solution and high-speed mixing granulation.
Career Highlights
Kengo Ikegami is currently associated with Tanabe Seiyaku Company, Limited, where he continues to innovate in the pharmaceutical sector. His work focuses on improving drug formulations to enhance patient compliance and therapeutic efficacy.
Collaborations
Ikegami has collaborated with notable colleagues such as Takashi Ishibashi and Keigo Nagao. Their combined expertise contributes to the advancement of pharmaceutical technologies.
Conclusion
Kengo Ikegami's contributions to sustained-release preparations demonstrate his commitment to improving drug delivery systems. His innovative patents and collaborations highlight his role as a key figure in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile